Innoblative Gets FDA IDE Nod for Breast Cancer Device
April 10, 2025
Innoblative prepares to initiate its feasibility study, evaluating the safety and effectiveness of its SIRA® RFA Electrosurgical Device, an FDA Breakthrough Device, for patients undergoing breast-conserving